ATM mediates pRB function to control DNMT1 protein stability and DNA methylation.

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• The retinoblastoma tumor suppressor gene (RB) product binds chromatin modifiers, suggesting a role in epigenetic gene regulation.
• The precise biological and clinical significance of RB's interaction with chromatin modifiers remains unclear.

Purpose of the Study:

• To investigate the biological and clinical significance of RB's epigenetic regulatory activity.
• To elucidate the mechanisms by which RB influences gene expression and tumor progression.

Main Methods:

• Genetic and epigenetic analyses were conducted in an Rb-deficient mouse thyroid C cell tumor model.
• Investigated the interaction between RB, ATM, DNMT1, Tip60, and UHRF1.
• Assessed DNA methylation status in target gene promoters.

Main Results:

• RB and ATM genetically interact to regulate DNMT1 protein stability and DNA methylation at specific gene promoters (Ink4a, Shc2, FoxO6, Noggin).
• pRB inactivation promotes Tip60-dependent ATM activation, leading to ATM binding with DNMT1, Tip60, and UHRF1.
• This complex accelerates DNMT1 ubiquitination, driven by Tip60-dependent acetylation.

Conclusions:

• Inactivation of the pRB pathway and DNA damage response aberrations deregulate DNMT1 stability.
• This deregulation results in aberrant DNA methylation patterns and contributes to malignant progression in thyroid cancer.